Metabolic syndrome is more likely to develop in postmenopausal survivors of breast cancer than in postmenopausal women who never had the disease.
There is insufficient evidence to determine that hormonal contraceptives do not influence glucose and lipid metabolism in women with diabetes mellitus, concluded a systematic review conducted by the Cochrane Fertility Regulation Group.
Early use of combination therapy to treat type 2 diabetes is shown to limit glucose toxicity and preserve beta-cell function.
Statin use in postmenopausal women is associated with an increased risk of new-onset diabetes mellitus, according to a new study published in the Archives of Internal Medicine.
New research shows that the SIRT3 gene may contribute to obesity as well as a variety of chronic diseases including diabetes, heart disease, and high blood pressure. The study was published in the August 18th issue of Molecular Cell.
With the rate of diabetes and prediabetes/glucose intolerance increasing, it is imperative for clinicians to help reduce the risk of their patients developing full-blown diabetes as well as to help patients manage the illness.
The duration of breast-feeding is associated with higher maternal ghrelin and pancreatic peptide YY (PYY) levels at three years postpartum, independent of other risk factors for metabolic disease, according to a study published in the April issue of Diabetes.
Diabetes appears to be associated with a decreased risk of prostate cancer in men but an increased risk of other cancer types in both men and women, according to research presented at the annual meeting of the American Association for Cancer Research, held April 2 to 6 in Orlando, Fla.
Supplementation with safflower (SAF) oil improves glycemia, inflammation, and blood lipids compared to treatment with conjugated linoleic acid (CLA) in postmenopausal obese women, according to a study published online Jan. 12 in Clinical Nutrition.
Body mass index (BMI), waist circumference, and waist-to-hip ratio all have a similar strength of association with cardiovascular disease, but do not significantly improve risk prediction when information on blood pressure, diabetes, and lipid levels is available, according to a study published online March 11 in The Lancet.